Rezolute - Rasio total nilai perusahaan marang pendapatan RZLT

rezolutebio.com (RZLT) - logo korporat

Rezolute, Inc. (RZLT) develops unique treatments for rare endocrine pathologies, including the drug RZ358. The company aims to secure a monopoly position within the orphan drug niche for hyperinsulinism. Anticipation of final Phase 3 trial data is driving the price action. The EV/Revenue multiple demonstrates financial stability excluding debt, with the current value standing at 0.00, helping to avoid overpaying for the asset.

RZLT Rezolute, Inc.: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

rezolutebio.com - rincian analitis lan metrik utama (RZLT)

- rega saham lan prakiraan rega para ahli:
Pambiji fundamental:rezolutebio.com
Sampel barang Rezolute, Inc.

This indicator reflects the enterprise value (EV) minus net debt per unit of revenue, measuring the market premium paid for every dollar of current sales. For the biotech company Rezolute, Inc. (RZLT), the Enterprise Value to Sales ratio is currently secondary due to the stage of clinical trials. Analyzing the chart, an investor assesses the potential for future monopoly margins following drug approval. An increasing multiple confirms market confidence in the scalability of the molecules.

Analisis pesaing

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)